Related Experiment Video
Updated: Mar 8, 2026

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
Published on: November 8, 2015
Tacrolimus-associated Diffuse Gastrointestinal Ulcerations and Pathergy: A Case Report
D Pan1, O Shaye1, J A Kobashigawa1
1Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California.
Tacrolimus toxicity can cause rare gastrointestinal ulcerations and pathergy in heart transplant patients. This case highlights the need to recognize unusual side effects of this common immunosuppressant.
Area of Science:
- Immunology
- Transplantation Medicine
- Gastroenterology
Background:
- Tacrolimus is a vital immunosuppressant used in organ transplantation and autoimmune diseases.
- Common side effects include nephrotoxicity, neurotoxicity, infection risk, and anemia.
- Understanding the full spectrum of tacrolimus toxicity is crucial for patient management.
Observation:
- A cardiac transplant recipient presented with an unusual manifestation of tacrolimus toxicity.
- The patient developed diffuse gastrointestinal ulcerations and pathergy.
- These symptoms are not typically associated with tacrolimus adverse effects.
Findings:
- This case report details a rare presentation of tacrolimus-induced gastrointestinal ulcerations and pathergy.
- The findings expand the known side effect profile of tacrolimus.
- This highlights the importance of considering drug toxicity in complex patient presentations.
Implications:
- Clinicians should be aware of rare gastrointestinal manifestations of tacrolimus toxicity.
- Early recognition and management of these unusual side effects can improve patient outcomes.
- Further research may elucidate the mechanisms behind this rare tacrolimus toxicity.
Related Concept Videos
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Drug Toxicity: Allergic Reactions
Hypersensitivity Reactions: Cytolytic Reactions
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

